| J9299 | Injection, nivolumab, 1 mg | 12,520 | $20 | $300.5K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 2,760 | $40 | $99.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 700 | $110 | $73.8K |
| J0897 | Injection, denosumab, 1 mg | 3,360 | $20 | $60.5K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 48,000 | $1 | $48K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 580 | $70 | $41.5K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 120 | $340 | $39.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 270 | $120 | $30.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 150 | $150 | $23.6K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 290 | $70 | $19.6K |